Blockbuster Drugs by
"Dr. Li now delivers an insider's account of how the drug industry ascended to its plateau and explores the nature of the turmoil it faces in the coming years. He begins with a survey of the landscape before "blockbuster drugs," and proceeds to describe how those drugs were discovered and subsequently became integral to the business models of large pharmaceutical companies."
FDA in the Twenty-First Century by
"With essays by leading scholars and government and private industry experts, FDA in the Twenty-First Century addresses perennial and new problems and the improvements the agency can make to better serve the public good."
A Prescription for Change by
"The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes--and indeed because of them--our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century."
Understanding Pharma: The Professional's Guide To How Pharmaceutical And Biotech Companies Really Work, 3rd Edition by
Understanding Pharma is a must-read for anyone in the pharma/biotech sector--those new to the industry, industry veterans, and specialized experts working in or serving the industry.
Pharmaceutical Supply Chain: Drug Quality and Security Act by 
Code Blue: inside America's medical industrial complex by 
China Rx : exposing the risks of America's dependence on China for medicine by 
Gene Jockeys by
Gene Jockeys is a detailed study of the biotech projects that led to five of the first ten recombinant DNA drugs to be approved for medical use in the United States: human insulin, human growth hormone, alpha interferon, erythropoietin, and tissue plasminogen activator.
Drug Discovery: Practices, Processes, and Perspectives by
Exploring all major therapeutic areas, the book introduces readers to all facets and phases of drug discovery, including target selection, biological testing, drug metabolism, and computer-assisted drug design.
Ten Drugs: How plants, powders, and pills have shaped the history of medicine by
Behind every landmark drug is a story.
Physician Characteristics and Distribution in the US by 
Remaking the American Patient: How Madison Avenue and Modern Medicine Turned Patients Into Consumers by 
Pharmaceutical Economics and Policy by 
The Right Price: a value-based prescription for drug costs by
"The Right Price sheds light on the controversial topic of drug pricing by providing an accessible guide to pharmaceutical markets and analytic techniques used to measure the value of drug therapies. It illustrates the need for value-based pricing through real-life stories of patients and their
experiences with the drug industry and explains why simple solutions like price controls and the importation of cheaper drugs from other countries are problematic."
Call numbers tell you where a book is shelved. It is the "address" of the book.
The Drexel Library uses Library of Congress Classification which groups titles by subject matter.
The following call number ranges are assigned to the Pharmaceutical industry, and to related topics.
HD9665-HD9675 Pharmaceutical industry
KF1879 Law - Drug & pharmaceutical industry U.S.
R7275 Medical personnel & other professions
RA401-RA402 Pharmaceutical policy
RA975.5 P5 Pharmacies. Drug distribution systems
RM300-RM666 Drugs and their actions
RS1-RS441 Pharmacy and materia medica
RS152 Hospital pharmacy
RS100.5 Pharmaceutical ethics
R724-R726.2 Medical ethics
